GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ovation Science Inc (XCNQ:OVAT) » Definitions » Days Sales Outstanding

Ovation Science (XCNQ:OVAT) Days Sales Outstanding : 231.17 (As of Dec. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Ovation Science Days Sales Outstanding?

Ovation Science's average Accounts Receivable for the three months ended in Dec. 2023 was C$0.04 Mil. Ovation Science's Revenue for the three months ended in Dec. 2023 was C$0.02 Mil. Hence, Ovation Science's Days Sales Outstanding for the three months ended in Dec. 2023 was 231.17.

The historical rank and industry rank for Ovation Science's Days Sales Outstanding or its related term are showing as below:

XCNQ:OVAT' s Days Sales Outstanding Range Over the Past 10 Years
Min: 22.87   Med: 101.48   Max: 296.71
Current: 296.71

During the past 7 years, Ovation Science's highest Days Sales Outstanding was 296.71. The lowest was 22.87. And the median was 101.48.

XCNQ:OVAT's Days Sales Outstanding is ranked worse than
96.89% of 998 companies
in the Drug Manufacturers industry
Industry Median: 71.84 vs XCNQ:OVAT: 296.71

Ovation Science's Days Sales Outstanding increased from Dec. 2022 (112.80) to Dec. 2023 (231.17).

Warning Sign:

If a company's sales outstanding increases, it means it has difficulty collecting payments from its customers.


Ovation Science Days Sales Outstanding Historical Data

The historical data trend for Ovation Science's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ovation Science Days Sales Outstanding Chart

Ovation Science Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
Get a 7-Day Free Trial 52.57 22.87 102.20 174.57 164.84

Ovation Science Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 112.80 127.97 2,805.94 1,528.44 231.17

Competitive Comparison of Ovation Science's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Ovation Science's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ovation Science's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ovation Science's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Ovation Science's Days Sales Outstanding falls into.



Ovation Science Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Ovation Science's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (0.053 + 0.003) / 2 ) / 0.062*365
=0.028 / 0.062*365
=164.84

Ovation Science's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding (Q: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Sep. 2023 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (0.073 + 0.003) / 2 ) / 0.015*365 / 4
=0.038 / 0.015*365 / 4
=231.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ovation Science  (XCNQ:OVAT) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Ovation Science Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Ovation Science's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Ovation Science (XCNQ:OVAT) Business Description

Traded in Other Exchanges
Address
625 Howe Street, Suite 1140, Vancouver, BC, CAN, V6C 2T6
Ovation Science Inc is a Canada-based company mainly engaged in the business of sub-licensing rights to use Invisicare, a patented drug delivery technology used in topical and transdermal skin products containing hemp seed oil and cannabis products. The company also holds the right to manufacture, distribute, sell, market, sub-license and promote products formulated with Invisicare and containing cannabis products including cannabinoids, hemp seed oil and any synthetic derivatives of cannabis. It also develops formulas for skin product lines including topical and transdermal creams and lotions containing hemp seed oil and cannabis.
Executives
David K. Ryan Director

Ovation Science (XCNQ:OVAT) Headlines

No Headlines